Viral Retinitis following Intraocular or Periocular Corticosteroid Administration: A Case Series and Comprehensive Review of the Literature

References

• Wong RW, Jumper JM, McDonald HR, et al. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013 May;97(5):545–52
   PubMed Web of Science ®Google Scholar
• Kanoff J, Sobrin L. New diagnosis and treatment paradigms in acute retinal necrosis. Int Ophthalmol Clin. 2011;51:25–31
   PubMedGoogle Scholar
• Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome–bench to bedside: LXVII Edward Jackson Memorial Lecture. American J Ophthalmol. 2011;151:198–216.e1
   PubMed Web of Science ®Google Scholar
• Thorne JE, Holbrook JT, Jabs DA, et al. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 2007;114:591–598
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr. Cytomegalovirus: ophthalmic perspectives on a pervasive pathogen. Expert Rev Ophthalmol. 2011;6:489–491
   Google Scholar
• Dalessandro L, Bottaro E. Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis. 2002;34:780–782
   PubMedGoogle Scholar
• Saidel M, Berreen J, Margolis T. Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol. 2005;140:1141–1143
   PubMed Web of Science ®Google Scholar
• Aggermann T, Stolba U, Brunner S, Binder S. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection. Ophthalmologica. 2006;220:131–133
   PubMedGoogle Scholar
• Toh T, Borthwick JH. Acute retinal necrosis post intravitreal injection of triamcinolone acetonide. Clin Exp Ophthalmol. 2006;34:380–382
   PubMed Web of Science ®Google Scholar
• Delyfer M-N, Rougier M-B, Hubschman J-P, et al. Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand. 2007;85:681–683
   PubMedGoogle Scholar
• Furukawa M. Cytomeglaovirus Retinitis after intravitreal triamcinolone acetonide treatment of a vitrectomized eye in an immunocompetent patient. Retin Cases Brief Rep. 2007;1(4):205--7
   Google Scholar
• Hsu J. Cytomegalovirus retinitis after treatment with intravitreal triamcinolone acetonide in an immunocompetent patient. Retinal Case Brief Rep. 2007;1:208–210
   PubMedGoogle Scholar
• Ufret-Vincenty RL, Singh RP, Kaiser PK. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol. 2007;143:334–335
   PubMed Web of Science ®Google Scholar
• Park YS, Byeon SH. Cytomegalovirus retinitis after intravitreous triamcinolone injection in a patient with central retinal vein occlusion. Korean J Ophthalmol. 2008;22:143–144
   PubMedGoogle Scholar
• Sekiryu T, Iida T, Kaneko H, Saito M. Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient. Jpn J Ophthalmol. 2008;52:414–416
   PubMed Web of Science ®Google Scholar
• Ramaiya KJ, Rao PK. Herpetic necrotizing retinitis following flucinolone acetonide intravitreal implant. Ocul Immunol Inflamm. 2011;19:72–74
   PubMed Web of Science ®Google Scholar
• Babiuch AS, Ravage ZB, Merrill PT. Cytomegalovirus acute retinal necrosis in an immunocompetent patient after sub-Tenon triamcinolone injection. Retinal Cases Brief Rep. 2010;4:364–365
   PubMedGoogle Scholar
• Chang S, Weissgold DJ, Singer JA, Sobrin L. Acute Retinal Necrosis following Intraocular Triamcinolone Acetonide Injection. Retin Cases Brief Rep. 2010 Fall;4(4):306--308
   Google Scholar
• Shah AM, Oster SF, Freeman WR. Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities. Am J Ophthalmol. 2010;149:433–440.e1
   PubMedGoogle Scholar
• Toyokawa N, Kimura H, Kuroda S. Cytomegalovirus retinitis after subtenon TA and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus. Jpn J Ophthalmol. 2010;54:166–168
   PubMedGoogle Scholar
• Tugal-Tutkun I, Araz B, Cagatay A. CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet's uveitis. Int Ophthalmol. 2010;30:591–593
   PubMedGoogle Scholar
• Vertes D, Snyers B, De Potter P. Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: a warning for the widespread use of intravitreous corticosteroids. Int Ophthalmol. 2010;30:595–597
   PubMedGoogle Scholar
• Han JM, Ahn J, Park KH, Woo SJ. Presumed necrotizing viral retinitis after intravitreal triamcinolone injection: case report. Korean J Ophthalmol. 2011;25:451–454
   PubMedGoogle Scholar
• Zaborowski AG. Cytomegalovirus retinitis following intravitreal triamcinolone acetonide in a patient with chronic uveitis on systemic immunosuppression. Ocul Immunol Inflamm. 2013 Apr;21(2):148--9
   Google Scholar
• Gupta S, Vemulakonda GA, Suhler EB, et al. Cytomegalovirus retinitis in the absence of AIDS. Can J Ophthalm. 2013;48:126–129
   PubMedGoogle Scholar
• Shale MJ, Seow CH, Coffin CS, et al. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease. Aliment Pharmacol Ther. 2009; 31:20–34
   Google Scholar
• Che H, Lukas C, Morel J, Combe B. Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: systemic review and meta-analysis. Joint Bone Spine. 2013 Aug 7. pii: S1297-319X(13)00194-2. doi: 10.1016/j.jbspin.2013.07.009. [Epub ahead of print]
   Google Scholar
• Dalessandro L, Bottaro E. Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis. 2002;34:780–782
   PubMedGoogle Scholar
• Liang H, Liang Y, Chen H, et al. Role of cytomegalovirus infection in the pathogenesis of type 2 diabetes mellitus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003;17:351–353
   PubMedGoogle Scholar